Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:763245.
doi: 10.5402/2011/763245. Epub 2011 Jun 22.

Ten-year survival after liver resection for colorectal metastases: systematic review and meta-analysis

Affiliations

Ten-year survival after liver resection for colorectal metastases: systematic review and meta-analysis

Saleh Abbas et al. ISRN Oncol. 2011.

Abstract

Background. Liver resection in metastatic colorectal cancer is proved to result in five-year survival of 25-40%. Several factors have been investigated to look for prognostic factors stratifications such as resection margins, node involvement in the primary disease, and interval between the primary disease and liver metastases. Methods. We searched MEDLINE and EMBASE for studies that reported ten-year survival. Metaanalysis was performed to analyse the effect of recognised prognostic factors on cure rate for colorectal metastases. The meta-analysis was performed according to Ottawa-Newcastle method of analysis for nonrandomised trials and according to the guidelines of the PRISMA. Results. Eleven studies were included in the analysis, which showed a ten-year survival rate of 12-36%. Factors that have favourable impact are clear resection margin, low level of CEA, single metastatic deposit, and node negative disease. The only factor that excluded patients from cure is the positive status of the resection margin. Conclusion. Predicted ten-year survival after liver resection for colorectal metastases varies from 12 to 36%. Only positive resection margins resulted in no 10-year survivors. No patient can be excluded from consideration for liver resection so long the result is negative margins.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of study selection process.
Figure 2
Figure 2
Positive and negative margins.
Figure 3
Figure 3
Resection margin less than 1 cm or more than 1 cm.
Figure 4
Figure 4
Tumour size.
Figure 5
Figure 5
Disease-free interval.
Figure 6
Figure 6
Nodal disease of the primary cancer.
Figure 7
Figure 7
Type of resection.
Figure 8
Figure 8
CEA level.
Figure 9
Figure 9
Distribution of liver lesions.
Figure 10
Figure 10
Number of liver lesions.
Figure 11
Figure 11
Synchronous versus metachronous metastases.
Figure 12
Figure 12
Blood transfusion.
Figure 13
Figure 13
Single versus multiple lesions.
Figure 14
Figure 14
Satellite lesions.

References

    1. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Annals of Surgery. 1999;230(3):309–321. - PMC - PubMed
    1. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Annals of Surgery. 2002;235(6):759–766. - PMC - PubMed
    1. Wagner JS, Adson MA, Van Heerden JA. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Annals of Surgery. 1984;199(5):502–508. - PMC - PubMed
    1. Petrowsky H, Gonen M, Jarnagin W, et al. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a Bi-institutional analysis. Annals of Surgery. 2002;235(6):863–871. - PMC - PubMed
    1. Mackay HJ, Billingsley K, Gallinger S, et al. A multicenter phase II study of “adjuvant” irinotecan following resection of colorectal hepatic metastases. American Journal of Clinical Oncology. 2005;28(6):547–554. - PubMed

LinkOut - more resources